Background Reports of waning vaccine-induced immunity against COVID-19 have begun to surface. With that, the comparable long-term protection conferred by previous infection with SARS-CoV-2 remains unclear. Methods We conducted a retrospective observational study comparing three groups: (1)SARS-CoV-2-naïve individuals who received a two-dose regimen of the BioNTech/Pfizer mRNA BNT162b2 vaccine, (2)previously infected individuals who have not been vaccinated, and (3)previously infected and single dose vaccinated individuals. Three multivariate logistic regression models were applied. In all models we evaluated four outcomes: SARS-CoV-2 infection, symptomatic disease, COVID-19-related hospitalization and death. The follow-up period of June 1 to August 14, 2021, when the Delta variant was dominant in Israel. Results SARS-CoV-2-naïve vaccinees had a 13.06-fold (95% CI, 8.08 to 21.11) increased risk for breakthrough infection with the Delta variant compared to those previously infected, when the first event (infection or vaccination) occurred during January and February of 2021. The increased risk was significant ( P

Text Document

Workers at Michigan-based Spectrum Health can avoid the company's COVID-19 vaccine mandate if they can prove they have ...

The immunity conferred by recovering from COVID-19 is better than the protection afforded by COVID-19 vaccines, a prominent ...

Prolonged SARS-CoV-2 RNA shedding and recurrence of PCR-positive tests have been widely reported in patients after recovery, yet these patients most commonly are non-infectious. Here we investigated the possibility that SARS-CoV-2 RNAs can be reverse-transcribed and integrated into the human genome …

The new coronavirus disease-2019 (COVID-19), which is spreading around the world and threatening people, is easily infecting a large number of people through airborne droplets; moreover, patients with hypertension, diabetes, obesity, and cardiovascular disease are more likely to experience severe co …

Endothelial insult and damage is one of the reported consequences of SARS-CoV-2 infection. It has been associated with severe inflammation, thrombotic phenomena and profound hypoxemia in critically ill patients. Endothelial activation leads to a loss of the endothelium's antithrombotic properties which, under normal conditions, are maintained by the endothelial glycocalyx, a carbohydrate-rich layer that covers the luminal surface of endothelial cells. In children, one of the serious forms of SARS-CoV-2 virus disease (COVID-19) is multisystem inflammatory syndrome (MIS-C). This new disease is characterized by a large inflammatory response and frequent cardiovascular, cutaneous and gastrointestinal disorders. We describe the first two cases of critically ill children with MIS-C who evidenced a large inflammatory response associated with elevated plasma and imaging biomarkers of endothelial activation and endothelial glycocalyx degradation. This microcirculation involvement in MIS-C could, at least partially, explain some of the clinical manifestations and laboratory and imaging alterations found in these patients. These findings contribute to a better understanding of this disease and suggest that medications to modulate the inflammatory response and protect or restore the endothelial glycocalyx should be considered in future studies.

In Sayer's latest interview, he dives deep with one of the world's foremost experts on vitamin C therapy, juxtaposing the extreme controversy and hype around ivermectin with this far more suppressed, effective, safe, affordable and available therapy that virtually no one is talking about despite its clinically validated role, and over 80 years of research proving its relevance to our times!

Dr. Anthony Fauci, a top U.S. public health official, said that a new study regarding so-called natural immunity ...

The two main COVID-19 vaccines used in the United States are more likely to land teenage boys in ...

The novel coronavirus disease (COVID-19) is caused by a virus (SARS-Cov-2) and is known for inducing multisystem organ dysfunction associated with significant morbidity and mortality. Current therapeutic strategies for COVID-19 have failed to effectively ...

In this interview, Stephanie Seneff, Ph.D., and Judy Mikovits, Ph.D., a dream-team in terms of deep insights into the scientific details, explain the problems they see with gene-based COVID-19 vaccines. There is a load of highly useful technical inf…

ICAN, through its attorneys, has sued the National Institutes of Health (NIH) for failing to respond to ICAN’s demand for the proof that Dr. Fauci claimed exists to prove NIH […]

New documents have been released detailing U.S.-funded research on various types of coronaviruses at the Wuhan Institute of Virology ...

In part one of this American Thought Leaders episode, mRNA vaccine inventor Dr. Robert Malone explained the latest ...

“We need to confront the data … not try to cover stuff up or hide risks,” says mRNA ...

Mt.Vernon, IN School Board Meeting .....TRUST THE SCIENCE — Narrative Destroyed in 6 min 32 sec —

#TruthArmy    #TruthOverProfits     #BelieveMoms   Recently, the World Health Organization (WHO) released a statement that they had worked with

PLEASE SPREAD LINK ACROSS ALL GROUPS/PEOPLE ON INSTAGRAM/FACEBOOK/WHATSAPP/TWITTER ETC Documentary that exposes WHO. Don't just listen to bias media. Is the WHO sick? The filmmaker and mother Lilian Franck reveals clandestine influences by the…

Monoclonal antibody treatments can help the body make antibodies for itself in people who test positive for COVID-19. Learn what they are and how they work in your body.